Lengthening the overnight fasting interval to at least 13 hours may be a novel, easily adoptable strategy to reduce breast cancer recurrence risk.... More »
SAN FRANCISCO – African American patients with clear-cell renal cell carcinoma may have poorer survival in part because of genomic factors that rend... More »
The use of endoscopic mucosal resection before radiofrequency ablation significantly reduced the risk for treatment failure among patients with Barret... More »
Ovarian suppression with triptorelin during chemotherapy for early-stage breast cancer significantly increased the chances that women would recover th... More »
The overall incidence of invasive cancer in the United States was 440.3 per 100,000 persons for 2012, the Centers for Disease Control and Prevention reported Dec. 17.
More than 1.5 million such...
SAN ANTONIO – The investigational oral tyrosine kinase inhibitor neratinib showed continued benefit in terms of reduced invasive disease-free survival at 3 years of follow-up in women with...
SAN ANTONIO – Prophylactic beta-blockade with bisoprolol during adjuvant trastuzumab therapy for HER2-positive breast cancer prevented trastuzumab-induced decline in left ventricular ejection...
